triazoles has been researched along with flucytosine in 112 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (13.39) | 18.7374 |
1990's | 16 (14.29) | 18.2507 |
2000's | 52 (46.43) | 29.6817 |
2010's | 28 (25.00) | 24.3611 |
2020's | 1 (0.89) | 2.80 |
Authors | Studies |
---|---|
Bava, AJ; Negroni, R | 1 |
Hughes, CE; Terrell, CL | 1 |
Cook, RA; Galgiani, JN; McIntyre, KA | 1 |
Polak, A | 2 |
Walsh, TJ | 1 |
Pizzo, A; Walsh, TJ | 1 |
Ackerbauer, H; Meingassner, JG; Mieth, H | 1 |
Abbott, AB; Cockayne, A; Hayward, J; Odds, FC | 1 |
Abruzzo, GK; Bulmer, GS; Fromtling, RA | 1 |
van 't Wout, JW; van Furth, R | 1 |
Hermans, PE; Terrell, CL | 1 |
Abruzzo, GK; Capizzi, TP; Fromtling, RA; Giltinan, DM | 1 |
Plempel, M | 2 |
Gerding, DN; Harris, C; Hughes, CE; Moody, JA; Peterson, LR | 1 |
Heins, J; Heins, S; Rumler, W | 1 |
Dismukes, WE | 1 |
Graybill, JR; Holmberg, JD; Luther, MF; Najvar, LK | 1 |
Björkholm, M | 1 |
Craig, AJ; Love, DN; Malik, R; Martin, P; Wigney, DI | 1 |
Chanock, SJ; Walsh, TJ | 1 |
Jones, RN; Messer, S; Pfaller, MA | 1 |
Hollis, RJ; Pfaller, MA; Zhang, J | 1 |
Jones, RN; Marco, F; Messer, S; Pfaller, MA | 1 |
Jones, RN; Marco, F; Messer, SA; Pfaller, MA | 2 |
Andriole, VT | 1 |
Coleman, DC; Gee, S; Joly, S; Messer, SA; Pfaller, MA; Pujol, C; Soll, DR; Sullivan, DJ | 1 |
de Pauw, BE; Kullberg, BJ | 1 |
Amariglio, N; Bielorai, B; Golan, H; Kaplinisky, C; Keller, N; Mandel, M; Neumann, Y; Paswell, J; Rechavi, G; Toren, A; Weintraub, M; Wolach, B | 1 |
Chatwani, A; Nyirjesy, P; Sood, G; Weitz, MV | 1 |
Kämmerer, R; Klempien, I; Kujath, P; Muhl, E | 1 |
Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
Barchiesi, F; Bocanegra, R; Carle, F; Caselli, F; Di Cesare, S; Di Francesco, LF; Giacometti, A; Giannini, D; Graybill, JR; Najvar, LK; Scalise, G; Schimizzi, AM | 1 |
Discher, T; Friese, G; Füssle, R; Lohmeyer, J; Schmalreck, A | 1 |
Cuenca-Estrella, M; Gómez-López, A; Monzón, A; Rodriguez-Tudela, JL | 1 |
Ernst, EJ; Klepser, ME; Roling, EE; Yodoi, K | 1 |
Odds, FC; Sanglard, D | 1 |
Ellepola, AN; Samaranayake, LP | 1 |
Gea-Banacloche, JC; Glasmacher, A; Groll, AH; Just-Nuebling, G; Maschmeyer, G; Walsh, TJ | 1 |
Buitrago, MJ; Cuenca-Estrella, M; Gomez-Lopez, A; Mellado, E; Monzón, A; Rodriguez-Tudela, JL | 2 |
del Palacio, A; Garau, M; Pereiro, M | 1 |
Bliss, JM; Gigliotti, F; Wellington, M | 1 |
Fujihara, N; Ichiyama, S; Iinuma, Y; Kudo, T; Saito, T; Takakura, S | 1 |
Arechavala, A; Bianchi, MH; Helou, SH; Negroni, R; Petri, N; Robles, AM | 1 |
Boyken, L; Diekema, DJ; Hollis, RJ; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Schwartz, S; Thiel, E | 1 |
Gil-Lamaignere, C; Müller, FM; Zhu, LP | 1 |
Al-Fattani, MA; Douglas, LJ | 1 |
Baldassarri, I; Barchiesi, F; Fothergill, AW; Maracci, M; Rinaldi, MG; Scalise, G; Spreghini, E | 1 |
Marr, KA | 1 |
Deresinski, S; Song, JC | 1 |
Steinbach, WJ | 1 |
Chen, R; Liao, W; Yao, Z | 1 |
Benjamin, DK; Steinbach, WJ; Zaoutis, TE | 1 |
Fohrer, C; Herbrecht, R; Letscher-Bru, V; Natarajan-Amé, S; Nivoix, Y | 1 |
Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
Guarro, J; Marimon, R; Mariné, M; Pastor, FJ; Serena, C | 1 |
Alvarado-Ramírez, E; Torres-Rodríguez, JM | 1 |
Almyroudis, NG; Fothergill, AW; Kusne, S; Rinaldi, MG; Sutton, DA | 1 |
Guarro, J; Mariné, M; Pastor, FJ; Rodríguez, MM; Serena, C | 1 |
Lewis, RE | 1 |
Andes, D; Kethireddy, S | 1 |
Chen, SC; Sorrell, TC | 1 |
Diekema, DJ; Pfaller, MA; Procop, GW; Rinaldi, MG | 1 |
Khakoo, RA; Khan, FA; Slain, D | 1 |
Auler, ME; Dias, AL; Gandra, RF; Gonçalves da Silva, E; Matsumoto, FE; Melhem, MS; Paula, CR; Ruiz, LS; Szeszs, MW | 1 |
Andes, D; Smith, J | 1 |
Mercier, RC; Pai, MP; Samples, ML; Spilde, MN | 1 |
Cuenca-Estrella, M; Dos Anjos Martins, M; Gomez-Lopez, A; Melhem, MC; Rodriguez-Tudela, JL; Zaragoza, O | 1 |
Altas, K; Boekhout, T; Kantarcioğlu, AS; Yücel, A | 1 |
Balasubramaniam, B; Dick, A; Johnson, E; Mayer, E; Narendran, N | 1 |
Choi, CW; Joo, SI; Kim, BS; Kim, EC; Kim, TU; Kim, YK; Lee, KM; Lee, YS; Yoo, JI; Yun, SH | 1 |
Maesaki, S; Tarumoto, N | 1 |
Alastruey-Izquierdo, A; Araujo Ribeiro, M; Cuenca-Estrella, M; Gomez-Lopez, A; Rodriguez-Tudela, JL | 1 |
Guarro, J; Mariné, M; Pastor, FJ | 1 |
Gerlach, U; Guckelberger, O; Jörres, D; Kohler, S; Neuhaus, P; Pascher, A; Pratschke, J; Sauer, IM | 1 |
Asari, S; Iwatani, Y; Nishi, I; Sunada, A; Toyokawa, M | 1 |
Danzi, M; Marino, A; Mungiguerra, M; Pisano, L; Ricciardi, AM; Ricciardi, R | 1 |
Avolio, M; Bruschetta, G; Camporese, A; De Rosa, R; Grosso, S | 1 |
Amorim, CS; Briones, MR; Colombo, AL; Gonçalves, SS; Melo, AS; Nucci, M; Padovan, AC | 1 |
Bonnal, C; Bouges-Michel, C; Bretagne, S; Chochillon, C; Dannaoui, E; Datry, A; Develoux, M; Dromer, F; Matheron, J; Paugam, A | 1 |
Borman, AM; Houbraken, J; Rijs, AJ; Samson, RA; Verweij, PE | 1 |
Bartlett, KH; Boekhout, T; Geertsen, E; Hagen, F; Illnait-Zaragozi, MT; Klaassen, CH; Meis, JF; Swinne, D | 1 |
Nweze, EI; Ogbonnaya, UL | 1 |
Jullien, V | 1 |
Meurman, JH; Pärnänen, P; Samaranayake, LP; Seneviratne, CJ; Vaara, M; Wong, SS; Yuen, KY | 1 |
Click, J; Gee, SN; Hsu, MY; Rothschild, B; Saavedra, A; Sheth, V | 1 |
Allada, G; Garrett, L; Marr, K; West, S | 1 |
Hamoud, S; Hayek, T; Keidar, Z | 1 |
Kontoyiannis, DP | 1 |
Bedin, M; D'Angelo, M; Gion, M; Grandesso, S; Mazzuccato, S; Sapino, B; Solinas, M | 1 |
Kim, HR; Lee, MK; Yu, N | 1 |
Al-Nakeeb, Z; Felton, TW; Goodwin, J; Gregson, L; Hope, WW; Howard, SJ; Jeans, AR; Sudan, A; Warn, PA | 1 |
Bicmen, C; Doluca, M; Gulat, S; Gunduz, AT; Tuksavul, F | 1 |
Su, J; Sun, W; Xu, S; Yan, D | 1 |
Choi, HJ; Ju, MY; Jung, SI; Kim, SH; Lee, K; Lee, WG; Park, YJ; Shin, JH | 1 |
Furuya, N; Mano, Y; Morishige, H; Oguri, T | 1 |
Datta, S; Goel, N; Oberoi, JK; Prasad, K; Raveendran, R; Wattal, C | 1 |
Arakawa, S; Fujisawa, M; Osawa, K; Shigemura, K; Yoshida, H | 1 |
Andes, DR; Lepak, AJ | 1 |
Castanheira, M; Jones, RN; Messer, SA; Pfaller, MA | 1 |
Bulanda, M; Jagielski, T; Skóra, M | 1 |
Delarze, E; Sanglard, D | 1 |
Altamirano, R; Córdoba, S; Davel, G; Isla, MG; Szusz, W; Vivot, W | 1 |
Canteros, CE; Córdoba, S; Davel, G; Hevia, A; Isla, G; Szusz, W; Vivot, W | 1 |
Ader, F; Aguado, JM; Akova, M; Arendrup, MC; Arikan-Akdagli, S; Barnes, RA; Beigelman-Aubry, C; Blot, S; Bouza, E; Brüggemann, RJM; Buchheidt, D; Cadranel, J; Castagnola, E; Chakrabarti, A; Cornely, OA; Cuenca-Estrella, M; Denning, DW; Dimopoulos, G; Fortun, J; Gangneux, JP; Garbino, J; Groll, AH; Heinz, WJ; Herbrecht, R; Heussel, CP; Kibbler, CC; Klimko, N; Kullberg, BJ; Lagrou, K; Lange, C; Lass-Flörl, C; Lehrnbecher, T; Lewis, RE; Löffler, J; Lortholary, O; Maertens, J; Marchetti, O; Meis, JF; Munoz, P; Pagano, L; Ribaud, P; Richardson, M; Roilides, E; Ruhnke, M; Sanguinetti, M; Sheppard, DC; Sinkó, J; Skiada, A; Ullmann, AJ; Vehreschild, MJGT; Verweij, PE; Viscoli, C; Warris, A | 1 |
Ataollahy, N; Hammarström, H; Kondori, N; Lindberg, E | 1 |
Pea, F | 1 |
29 review(s) available for triazoles and flucytosine
Article | Year |
---|---|
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Thromboxane-A Synthase; Triazoles | 1992 |
Recent advances in the treatment of systemic fungal infections.
Topics: Acquired Immunodeficiency Syndrome; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1987 |
Treatment of systemic fungal infections: recent progress and current problems.
Topics: Amphotericin B; Antifungal Agents; Chemical Phenomena; Chemistry; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Triazoles | 1988 |
Management of cryptococcosis.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Flucytosine; Humans; Lung Diseases, Fungal; Meningitis; Triazoles | 1993 |
Chemoprophylaxis of fungal infections in neutropenic patients.
Topics: Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Neutropenia; Polyenes; Triazoles | 1994 |
Evolving concepts of prevention and treatment of invasive fungal infections in pediatric bone marrow transplant recipients.
Topics: Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Child; Clinical Trials as Topic; Fluconazole; Flucytosine; Humans; Imidazoles; Immunocompromised Host; Itraconazole; Mycoses; Neutropenia; Transplantation Conditioning; Triazoles | 1996 |
Current and future therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Drug Carriers; Flucytosine; Humans; Liposomes; Mycoses; Triazoles | 1998 |
Therapy of invasive fungal infections.
Topics: Amphotericin B; Antifungal Agents; Catheterization, Central Venous; Contraindications; Drug Therapy, Combination; Flucytosine; Fungemia; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Mycoses; Neutropenia; Triazoles | 1999 |
Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Oxidoreductases; Sterol 14-Demethylase; Triazoles | 2002 |
Oral candidal infections and antimycotics.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles | 2000 |
Clinical pharmacology of antifungal compounds.
Topics: Anti-Bacterial Agents; Antifungal Agents; Drug Design; Echinocandins; Flucytosine; Fungal Proteins; Humans; Immunocompromised Host; Molecular Structure; Mycoses; Peptides; Peptides, Cyclic; Polyenes; Triazoles | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Fluconazole; Flucytosine; Fungal Proteins; Fungemia; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Ketoconazole; Lipopeptides; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
CNS-aspergillosis: are there new treatment options?
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blood-Brain Barrier; Caspofungin; Central Nervous System Fungal Infections; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Lipopeptides; Male; Peptides; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2003 |
Invasive Candida infections: the changing epidemiology.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Flucytosine; Fungemia; Humans; Incidence; Prevalence; Risk Factors; Triazoles; United States | 2004 |
Hepatotoxicity of antifungal agents.
Topics: Allylamine; Animals; Antifungal Agents; Chemical and Drug Induced Liver Injury; Flucytosine; Humans; Imidazoles; Polyenes; Triazoles | 2005 |
Antifungal agents in children.
Topics: Age Factors; Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Chemistry, Pharmaceutical; Child; Clinical Trials as Topic; Drug Approval; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Patient Selection; Pediatrics; Peptides, Cyclic; Pyrimidines; Safety; Thiazoles; Triazoles; United States; Voriconazole | 2005 |
Antifungal treatment in pediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Azoles; Caspofungin; Child; Child, Preschool; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungal Proteins; Humans; Infant; Lipopeptides; Lipoproteins; Micafungin; Mycoses; Peptides, Cyclic; Triazoles | 2005 |
Management of systemic fungal infections: alternatives to itraconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles | 2005 |
Pharmacodynamic implications for use of antifungal agents.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Microbial Sensitivity Tests; Polyenes; Triazoles | 2007 |
CNS pharmacokinetics of antifungal agents.
Topics: Amphotericin B; Animals; Antifungal Agents; Central Nervous System; Flucytosine; Humans; Triazoles | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Candida endophthalmitis: focus on current and future antifungal treatment options.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Echinocandins; Endophthalmitis; Fluconazole; Flucytosine; Humans; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2007 |
Therapeutic drug monitoring of antifungals: pharmacokinetic and pharmacodynamic considerations.
Topics: Antifungal Agents; Drug Monitoring; Fluconazole; Flucytosine; Humans; Itraconazole; Mycoses; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Oral antifungal agents].
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Diabetes Complications; Fluconazole; Flucytosine; Humans; Itraconazole; Japan; Mycoses; Practice Guidelines as Topic; Pyrimidines; Triazoles; Voriconazole | 2008 |
[Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Topics: Amphotericin B; Antifungal Agents; Child; Echinocandins; Evidence-Based Medicine; Flucytosine; Humans; Mycoses; Triazoles | 2011 |
Invasive mycoses: strategies for effective management.
Topics: Adult; Alanine Transaminase; Alkaline Phosphatase; Antifungal Agents; Antineoplastic Agents; Aspartate Aminotransferases; Aspergillosis; Bilirubin; Biomarkers; Drug Monitoring; Echinocandins; Female; Flucytosine; Humans; Immunocompromised Host; Leukemia; Liver; Liver Function Tests; Male; Middle Aged; Mucormycosis; Mycoses; Myelodysplastic Syndromes; Opportunistic Infections; Pneumonia; Risk Factors; Triazoles | 2012 |
Antifungal pharmacokinetics and pharmacodynamics.
Topics: Animals; Antifungal Agents; Disease Models, Animal; Echinocandins; Flucytosine; Humans; Mice; Mycoses; Polyenes; Rabbits; Rats; Triazoles | 2014 |
Defining the frontiers between antifungal resistance, tolerance and the concept of persistence.
Topics: Amphotericin B; Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Drug Tolerance; Echinocandins; Flucytosine; Fungi; Host-Pathogen Interactions; Humans; Microbial Sensitivity Tests; Mycoses; Triazoles | 2015 |
From bench to bedside: Perspectives on the utility of pharmacokinetics/pharmacodynamics in predicting the efficacy of antifungals in invasive candidiasis.
Topics: Amphotericin B; Animals; Antifungal Agents; Antimicrobial Stewardship; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candida tropicalis; Candidiasis, Invasive; Echinocandins; Fluconazole; Flucytosine; Humans; Species Specificity; Triazoles; Voriconazole | 2020 |
83 other study(ies) available for triazoles and flucytosine
Article | Year |
---|---|
Comparative study of six antifungal treatments in an experimental model of murine cryptococcosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mice, Inbred BALB C; Triazoles | 1992 |
Effects of incubation temperature, inoculum size, and medium on agreement of macro- and microdilution broth susceptibility test results for yeasts.
Topics: Amphotericin B; Candida; Culture Media; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Temperature; Triazoles; Yeasts | 1990 |
Combination therapy of experimental candidiasis, cryptococcosis, aspergillosis and wangiellosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Drug Therapy, Combination; Exophiala; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Mice; Mycoses; Triazoles | 1987 |
[Experimental renal infection with Aspergillus fumigatus in mice: a chemotherapeutic model of an organic mycosis].
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Disease Models, Animal; Female; Flucytosine; Itraconazole; Ketoconazole; Kidney Diseases; Mice; Mice, Inbred Strains; Miconazole; Triazoles | 1985 |
Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Clotrimazole; Flucytosine; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Triazoles | 1985 |
Cryptococcus neoformans: comparisons of in vitro antifungal susceptibilities of serotypes AD and BC.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Flucytosine; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Nystatin; Serotyping; Triazoles | 1986 |
Chemotherapy of the pulmonary mycoses. This Official Statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1987.
Topics: Amphotericin B; Flucytosine; Humans; Imidazoles; Lung Diseases; Mycoses; Triazoles | 1988 |
[Antimycotic agents in generalized fungal infections].
Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles | 1988 |
Antifungal agents used for deep-seated mycotic infections.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Humans; Imidazoles; Mycoses; Triazoles | 1987 |
Influence of six antifungal agents on the chemiluminescence response of mouse spleen cells.
Topics: Amphotericin B; Animals; Antifungal Agents; Female; Flucytosine; Luminescent Measurements; Mice; Miconazole; Oxygen Consumption; Phagocytes; Spleen; Triazoles | 1986 |
Antimycotic therapy of experimental infections caused by dematiaceous fungi.
Topics: Amphotericin B; Animals; Antifungal Agents; Dose-Response Relationship, Drug; Drug Therapy, Combination; Flucytosine; Fluorouracil; Humans; Ketoconazole; Male; Mice; Mitosporic Fungi; Mycoses; Triazoles | 1984 |
[Correlation of in vitro and in vivo actions of azole antimycotics].
Topics: Animals; Antifungal Agents; Candidiasis; Flucytosine; In Vitro Techniques; Ketoconazole; Male; Mice; Mice, Inbred Strains; Triazoles | 1984 |
In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Flucytosine; Ketoconazole; Microbial Sensitivity Tests; Rifampin; Triazoles | 1984 |
Antimycotic activity of BAY N 7133 in animal experiments.
Topics: Administration, Oral; Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Cryptococcosis; Female; Flucytosine; Guinea Pigs; Hair; Infusions, Parenteral; Ketoconazole; Male; Mice; Mycoses; Triazoles | 1984 |
[Relation between the antibiotic concentration and contact time of the effect of 5-fluorocytosine, bifonazole and Bay N 7133 on Candida albicans].
Topics: Antifungal Agents; Candida albicans; Cytosine; Flucytosine; Imidazoles; Microbial Sensitivity Tests; Solutions; Time Factors; Triazoles | 1984 |
Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
Topics: Animals; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Flucytosine; Mice; Mice, Inbred ICR; Triazoles | 1995 |
Combination chemotherapy of canine and feline cryptococcosis using subcutaneously administered amphotericin B.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Cat Diseases; Cats; Cryptococcosis; Dog Diseases; Dogs; Drug Administration Schedule; Drug Therapy, Combination; Flucytosine; Injections, Subcutaneous; Male; Triazoles | 1996 |
Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Saccharomyces cerevisiae; Triazoles | 1997 |
Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Triazoles | 1997 |
In vitro activities of voriconazole (UK-109,496) and four other antifungal agents against 394 clinical isolates of Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 1998 |
In vitro activity of a new triazole antifungal agent, Sch 56592, against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles | 1998 |
In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Peptides; Peptides, Cyclic; Pyrimidines; Thiazoles; Triazoles; Voriconazole | 1999 |
Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Pyrimidines; Triazoles; Voriconazole | 1998 |
Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Child, Preschool; Combined Modality Therapy; Drug Resistance, Microbial; Flucytosine; Granulocyte Colony-Stimulating Factor; Granulocytes; Granulomatous Disease, Chronic; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Leukocyte Transfusion; Lung Diseases, Fungal; Male; Neutrophils; Osteomyelitis; Pyrimidines; Respiratory Burst; Ribs; Triazoles; Voriconazole | 2000 |
Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Female; Flucytosine; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Vaginal Creams, Foams, and Jellies | 2000 |
[Invasive aspergillosis on a surgical intensive care unit].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Drug Therapy, Combination; Fatal Outcome; Female; Flucytosine; Humans; Intensive Care Units; Itraconazole; Male; Middle Aged; Pyrimidines; Risk Factors; Triazoles; Voriconazole | 2000 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Interactions of posaconazole and flucytosine against Cryptococcus neoformans.
Topics: Animals; Antifungal Agents; Colony Count, Microbial; Cryptococcosis; Cryptococcus neoformans; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Flucytosine; Male; Meningitis, Cryptococcal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Triazoles | 2001 |
Development of azole resistance during fluconazole maintenance therapy for AIDS-associated cryptococcal disease.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chorioretinitis; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Meningitis, Cryptococcal; Pneumonia; Prednisolone; Pyrimidines; Triazoles; Voriconazole | 2001 |
In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole.
Topics: Amphotericin B; Antifungal Agents; Flucytosine; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2001 |
Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.
Topics: Amphotericin B; Antifungal Agents; Candida; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Time Factors; Triazoles; Voriconazole | 2002 |
Scopulariopsis brevicaulis, a fungal pathogen resistant to broad-spectrum antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2003 |
In vitro susceptibilities of Malassezia species to a new triazole, albaconazole (UR-9825), and other antifungal compounds.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Flucytosine; In Vitro Techniques; Itraconazole; Ketoconazole; Malassezia; Microbial Sensitivity Tests; Pyrimidines; Quinazolines; Triazoles; Voriconazole | 2003 |
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Echinocandins; Flucytosine; Humans; Itraconazole; Japan; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2004 |
Case study: posaconazole treatment of disseminated phaeohyphomycosis due to Exophiala spinifera.
Topics: Adult; Antifungal Agents; Drug Therapy, Combination; Exophiala; Female; Flucytosine; Humans; Itraconazole; Mycoses; Pregnancy; Pregnancy Complications, Infectious; Triazoles | 2004 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Thiazoles; Triazoles | 2004 |
Effects of several antifungal drug combinations against clinical and environmental isolates of Cryptococcus neoformans from China.
Topics: Animals; Antifungal Agents; Caspofungin; China; Columbidae; Cryptococcosis; Cryptococcus neoformans; Drug Interactions; Echinocandins; Feces; Flucytosine; Humans; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Thiazoles; Triazoles | 2004 |
Penetration of Candida biofilms by antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Colony Count, Microbial; Culture Media; Diffusion; Fluconazole; Flucytosine; Microscopy, Electron, Scanning; Mutation; Pyrimidines; Staphylococcus epidermidis; Triazoles; Voriconazole | 2004 |
In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata.
Topics: Amphotericin B; Antifungal Agents; Candida glabrata; Drug Combinations; Drug Synergism; Flucytosine; Kinetics; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2004 |
Management of cryptococcosis in non-HIV-related patients.
Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Antifungal Agents; Central Nervous System Fungal Infections; Child; Child, Preschool; China; Cryptococcosis; Drug Therapy, Combination; Female; Flucytosine; Humans; Injections, Intravenous; Injections, Spinal; Itraconazole; Lung Diseases, Fungal; Male; Middle Aged; Retrospective Studies; Skin Diseases; Treatment Outcome; Triazoles | 2005 |
Head-to-head comparison of the activities of currently available antifungal agents against 3,378 Spanish clinical isolates of yeasts and filamentous fungi.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Fungi; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Spain; Triazoles; Voriconazole; Yeasts | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
Effect of antifungal treatment in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Fluconazole; Flucytosine; Geotrichosis; Geotrichum; Immunocompromised Host; Immunosuppressive Agents; Kidney; Liver; Male; Mice; Microbial Sensitivity Tests; Pyrimidines; Spleen; Survival Analysis; Treatment Outcome; Triazoles; Voriconazole | 2007 |
In vitro susceptibility of Sporothrix schenckii to six antifungal agents determined using three different methods.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Quality Control; Sporothrix; Sporotrichosis; Triazoles; Voriconazole | 2007 |
In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Flucytosine; Humans; In Vitro Techniques; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Mucormycosis; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole | 2007 |
Combined therapies in a murine model of blastoschizomycosis.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Echinocandins; Flucytosine; Geotrichosis; Geotrichum; Humans; Immunocompromised Host; Lipopeptides; Lipoproteins; Male; Micafungin; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Mycoses; Peptides, Cyclic; Pyrimidines; Survival Analysis; Triazoles; Trichosporon; Voriconazole | 2007 |
Multicenter comparison of the VITEK 2 antifungal susceptibility test with the CLSI broth microdilution reference method for testing amphotericin B, flucytosine, and voriconazole against Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Culture Media; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Reference Standards; Time Factors; Triazoles; Voriconazole | 2007 |
Antifungal susceptibility of bloodstream yeasts isolated at a public children's hospital in Brazil: comparison of the Etest and the AFST-EUCAST microdilution method.
Topics: Amphotericin B; Antifungal Agents; Blood; Brazil; Candida; Child; Child, Preschool; Fluconazole; Flucytosine; Hospitals, Public; Humans; Infant; Infant, Newborn; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Sensitivity and Specificity; Triazoles; Voriconazole | 2007 |
Activities and ultrastructural effects of antifungal combinations against simulated Candida endocardial vegetations.
Topics: Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Drug Therapy, Combination; Echinocandins; Endocarditis; Flucytosine; Humans; In Vitro Techniques; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Models, Biological; Pyrimidines; Triazoles; Voriconazole | 2008 |
In vitro susceptibility of Cryptococcus gattii clinical isolates.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus; Cryptococcus neoformans; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Triazoles | 2008 |
Susceptibility testing of Cryptococcus diffluens against amphotericin B, flucytosine, fluconazole, itraconazole, voriconazole and posaconazole.
Topics: Amphotericin B; Antifungal Agents; Azoles; Cryptococcus; Culture Media; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2009 |
Five-year retrospective review of guideline-based management of fungal endophthalmitis.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Drug Costs; Endophthalmitis; Eye Infections, Fungal; Female; Fluconazole; Flucytosine; Guideline Adherence; Health Care Costs; Humans; Male; Medical Audit; Middle Aged; Mycoses; Practice Guidelines as Topic; Pyrimidines; Retrospective Studies; Treatment Outcome; Triazoles; Visual Acuity; Voriconazole | 2008 |
National surveillance of antifungal susceptibility of Candida species in South Korean hospitals.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Hospitals; Humans; Microbial Sensitivity Tests; Population Surveillance; Pyrimidines; Republic of Korea; Triazoles; Voriconazole | 2009 |
Molecular identification and susceptibility testing of Trichosporon isolates from a Brazilian hospital.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cross Infection; Dermatomycoses; Drug Resistance, Fungal; Echinocandins; Female; Flucytosine; Fungemia; Hospitals, University; Humans; Mycological Typing Techniques; Mycoses; Onychomycosis; Opportunistic Infections; Organ Specificity; Triazoles; Trichosporon; Urine; Vaginitis | 2008 |
Combined antifungal therapy in a murine model of disseminated infection by Cladophialophora bantiana.
Topics: Amphotericin B; Animals; Antifungal Agents; Ascomycota; Disease Models, Animal; Drug Therapy, Combination; Echinocandins; Flucytosine; Humans; Lipopeptides; Male; Micafungin; Mice; Mycoses; Treatment Outcome; Triazoles | 2009 |
Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation.
Topics: Adult; Amphotericin B; Aspergillosis; Cerebrum; Female; Flucytosine; Humans; Immunocompromised Host; Intestines; Kidney Transplantation; Lung Diseases, Fungal; Neuroaspergillosis; Pyrimidines; Sphenoid Sinus; Triazoles; Voriconazole | 2009 |
In vitro antifungal combination effects of micafungin with fluconazole, voriconazole, amphotericin B, and flucytosine against clinical isolates of Candida species.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Synergism; Echinocandins; Fluconazole; Flucytosine; Humans; Lipopeptides; Micafungin; Pyrimidines; Triazoles; Voriconazole | 2009 |
[In vitro activity of voriconazole and other antifungal agents against clinical isolates of 138 Candida spp].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Species Specificity; Triazoles; Voriconazole | 2009 |
Direct antifungal susceptibility testing of positive Candida blood cultures by sensititre YeastOne.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Sensitivity and Specificity; Time Factors; Triazoles; Voriconazole | 2009 |
Prevalence rates and antifungal susceptibility profiles of the Candida parapsilosis species complex: results from a nationwide surveillance of candidaemia in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Caspofungin; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Flucytosine; Fungemia; Humans; Lipopeptides; Microbial Sensitivity Tests; Mycological Typing Techniques; Polyenes; Population Surveillance; Prevalence; Triazoles | 2010 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Fungemia; Itraconazole; Laboratories, Hospital; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reference Values; Triazoles; Voriconazole; Yeasts | 2010 |
Identification of Paecilomyces variotii in clinical samples and settings.
Topics: Amphotericin B; Antifungal Agents; DNA, Fungal; DNA, Ribosomal; DNA, Ribosomal Spacer; Flucytosine; Fungal Proteins; Genes, rRNA; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mycoses; Paecilomyces; Pyrimidines; RNA, Fungal; RNA, Ribosomal, 5.8S; Sequence Analysis, DNA; Triazoles; Tubulin; Voriconazole | 2010 |
In vitro antifungal susceptibilities and amplified fragment length polymorphism genotyping of a worldwide collection of 350 clinical, veterinary, and environmental Cryptococcus gattii isolates.
Topics: Amphotericin B; Amplified Fragment Length Polymorphism Analysis; Animals; Antifungal Agents; Cryptococcus gattii; Environmental Microbiology; Fluconazole; Flucytosine; Genotype; Humans; Microbial Sensitivity Tests; Nitriles; Pyridines; Pyrimidines; Triazoles; Voriconazole | 2010 |
Oral Candida isolates among HIV-infected subjects in Nigeria.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole | 2011 |
Antifungal susceptibility and virulence attributes of bloodstream isolates of Candida from Hong Kong and Finland.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Caspofungin; Drug Resistance, Fungal; Echinocandins; Finland; Fluconazole; Flucytosine; Hemolysin Proteins; Hong Kong; Humans; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Peptide Hydrolases; Pyrimidines; Triazoles; Virulence Factors; Voriconazole | 2011 |
Tender ulceronecrotic nodules in a patient with leukemia. Cutaneous acanthamebiasis.
Topics: Acanthamoeba; Amebiasis; Antiprotozoal Agents; Drug Therapy, Combination; Female; Fluconazole; Flucytosine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Middle Aged; Necrosis; Pentamidine; Phosphorylcholine; Pyrimidines; Skin Diseases, Parasitic; Skin Ulcer; Sulfadoxine; Triazoles; Voriconazole | 2011 |
74-year-old man from the pacific northwest with fever and a lung mass.
Topics: Aged; Amphotericin B; Antifungal Agents; British Columbia; Bromhexine; Cryptococcosis; Cryptococcus gattii; Flucytosine; Humans; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Radiography; Triazoles | 2011 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; Fever; Fluconazole; Flucytosine; Fungemia; Headache; Humans; Nausea; Pyrimidines; Recurrence; Saccharomyces cerevisiae; Triazoles; Voriconazole | 2011 |
[Study on in vitro susceptibility of Candida spp. isolated from blood culture].
Topics: Amphotericin B; Antifungal Agents; Blood; Candida; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Hospitals; Humans; In Vitro Techniques; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Pyrimidines; Reproducibility of Results; Risk Factors; Triazoles; Voriconazole | 2012 |
The first Korean case of candidemia due to Candida dubliniensis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidemia; Catheterization, Central Venous; Female; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Middle Aged; Pyrimidines; Triazoles; Voriconazole | 2012 |
Pharmacodynamics of itraconazole against Aspergillus fumigatus in an in vitro model of the human alveolus: perspectives on the treatment of triazole-resistant infection and utility of airway administration.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cells, Cultured; Drug Administration Routes; Drug Resistance, Fungal; Flucytosine; Galactose; Humans; Itraconazole; Lung Diseases, Fungal; Mannans; Microbial Sensitivity Tests; Pulmonary Alveoli; Triazoles | 2012 |
Species level identification and antifungal susceptibility of yeasts isolated from various clinical specimens and evaluation of Integral System Yeasts Plus.
Topics: Amphotericin B; Candida; Colorimetry; Drug Resistance, Multiple, Fungal; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Reagent Kits, Diagnostic; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Triazoles; Voriconazole | 2012 |
Trichosporon asahii causing nosocomial urinary tract infections in intensive care unit patients: genotypes, virulence factors and antifungal susceptibility testing.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Cross Infection; DNA, Fungal; DNA, Intergenic; Drug Resistance, Multiple, Fungal; Female; Flucytosine; Genetic Variation; Genotype; Hemolysin Proteins; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Pyrimidines; Triazoles; Trichosporon; Trichosporonosis; Urinary Tract Infections; Virulence Factors; Voriconazole | 2012 |
Antifungal susceptibility to amphotericin B, fluconazole, voriconazole, and flucytosine in Candida bloodstream isolates from 15 tertiary hospitals in Korea.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Pyrimidines; Republic of Korea; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Comparison of four reading methods of broth microdilution based on the clinical and laboratory standards institute M27-A3 method for Candida spp.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Lipopeptides; Micafungin; Miconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Non-albicans Candida species in blood stream infections in a tertiary care hospital at New Delhi, India.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Flucytosine; Humans; Incidence; India; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Tertiary Care Centers; Triazoles; Voriconazole | 2012 |
Candida urinary tract infection and Candida species susceptibilities to antifungal agents.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Flucytosine; Hospitals, University; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Pyrimidines; Retrospective Studies; Risk Factors; Triazoles; Urinary Tract Infections; Voriconazole | 2013 |
In vitro antifungal susceptibilities of isolates of Candida spp. and Aspergillus spp. from China to nine systemically active antifungal agents: data from the SENTRY antifungal surveillance program, 2010 through 2012.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Azoles; Candida; China; Drug Resistance, Fungal; Drug Resistance, Multiple, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Microbial Sensitivity Tests; Mutation; Rhodotorula; Sequence Analysis, DNA; Triazoles; Trichosporon; Voriconazole | 2015 |
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Caspofungin; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Lipopeptides; Microbial Sensitivity Tests; Scopulariopsis; Triazoles; Voriconazole | 2015 |
Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Argentina; Cryptococcosis; Cryptococcus neoformans; Drug Resistance, Fungal; Epidemiologic Methods; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Meningitis, Cryptococcal; Microbial Sensitivity Tests; Triazoles; Voriconazole | 2016 |
Molecular identification and susceptibility profile of Sporothrix schenckii sensu lato isolated in Argentina.
Topics: Animals; Antifungal Agents; Argentina; Calmodulin; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Phylogeny; Sequence Analysis, DNA; Soil Microbiology; Sporothrix; Sporotrichosis; Triazoles | 2018 |
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus; Biopsy; Bronchoalveolar Lavage; Disease Management; Early Diagnosis; Flucytosine; Galactose; Humans; Immunocompromised Host; Immunologic Tests; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Mannans; Microbial Sensitivity Tests; Myelodysplastic Syndromes; Nitriles; Pyridines; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2018 |
Species distribution and antifungal drug susceptibilities of yeasts isolated from the blood samples of patients with candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Anidulafungin; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida parapsilosis; Candidemia; Caspofungin; Child; Child, Preschool; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Male; Micafungin; Microbial Sensitivity Tests; Middle Aged; Triazoles; Voriconazole; Young Adult | 2019 |